Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.75M Buy
87,157
+80,526
+1,214% +$3.6M 0.01% 466
2026
Q1
$319K Sell
6,631
-1,992
-23% -$92.9K ﹤0.01% 1140
2025
Q4
$418K Buy
8,623
+2,430
+39% +$120K ﹤0.01% 906
2025
Q3
$292K Sell
6,193
-1,206
-16% -$58.2K ﹤0.01% 1047
2025
Q2
$357K Buy
7,399
+959
+15% +$49K ﹤0.01% 885
2025
Q1
$357K Buy
6,440
+79
+1% +$4.28K ﹤0.01% 771
2024
Q4
$307K Buy
6,361
+1,264
+25% +$64.3K ﹤0.01% 1101
2024
Q3
$294K Buy
5,097
+369
+8% +$19.9K ﹤0.01% 1098
2024
Q2
$229K Buy
+4,728
New +$228K ﹤0.01% 1086
2023
Q4
Sell
-3,865
Closed -$207K 870
2023
Q3
$207K Buy
+3,865
New +$206K ﹤0.01% 751

Other funds holding SNY

Savant Capital's SNY Position: Q2 2026 in Review

Savant Capital increased its Sanofi (SNY) stake by 1,214% in Q2 2026, buying an estimated $3.6M and bringing the position to 87,157 shares worth $3.75M. The position accounts for 0.01% of the portfolio, ranked #466.

Savant Capital first reported a position in SNY in Q3 2023 and has held it in 10 quarters since. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Savant Capital held 87,157 shares of Sanofi worth $3.75M as of Q2 2026.
  • Savant Capital bought 80,526 Sanofi shares in Q2 2026, an estimated $3.6M.
  • Sanofi made up 0.01% of Savant Capital's portfolio in Q2 2026, its #466 holding.
  • Savant Capital first reported a position in Sanofi in Q3 2023 and has held it in 10 quarters since.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.